His primary scientific interests are in Genetics, Genome-wide association study, Schizophrenia, Bipolar disorder and Single-nucleotide polymorphism. His work on Genetics deals in particular with Genetic association, Allele, Locus, Genetic linkage and Genotype. In his study, which falls under the umbrella issue of Genetic association, ANK3 and Genetic variation is strongly linked to Haplotype.
The Genome-wide association study study combines topics in areas such as Copy-number variation, Linkage disequilibrium, Case-control study, Major depressive disorder and Genetic architecture. His work in Major depressive disorder covers topics such as Meta-analysis which are related to areas like Age of onset. His study looks at the relationship between Schizophrenia and fields such as Disease, as well as how they intersect with chemical problems.
His primary areas of investigation include Genetics, Genome-wide association study, Psychiatry, Schizophrenia and Single-nucleotide polymorphism. His studies in Linkage disequilibrium, Allele, Genetic linkage, Genetic association and Gene are all subfields of Genetics research. His Genome-wide association study research is multidisciplinary, relying on both Case-control study, Genomics, Locus, Major depressive disorder and Genetic architecture.
Douglas F. Levinson has included themes like Internal medicine, Proband and Clinical psychology in his Psychiatry study. His Schizophrenia research incorporates elements of Bipolar disorder, Autism and Genome, Copy-number variation. His Single-nucleotide polymorphism research is multidisciplinary, incorporating elements of Genetic correlation, Polymorphism and Candidate gene.
Douglas F. Levinson mostly deals with Genome-wide association study, Major depressive disorder, Genetics, Schizophrenia and Psychiatry. The concepts of his Genome-wide association study study are interwoven with issues in Disease, Genetic predisposition, Linkage disequilibrium, Genetic association and Comorbidity. His studies deal with areas such as Meta-analysis, Internal medicine, Single-nucleotide polymorphism and Genetic architecture as well as Major depressive disorder.
He regularly ties together related areas like Schizophrenia in his Genetics studies. His work deals with themes such as Dual diagnosis, Bipolar disorder, Psychosis and Autism, which intersect with Schizophrenia. While the research belongs to areas of Psychiatry, he spends his time largely on the problem of Polygenic risk score, intersecting his research to questions surrounding Heterogeneous disorder and Polygene.
His main research concerns Genome-wide association study, Major depressive disorder, Psychiatry, Genetics and Bipolar disorder. His Genome-wide association study research incorporates themes from Case-control study, Schizophrenia, Disease and Genetic architecture. Douglas F. Levinson interconnects Meta-analysis, Genetic heterogeneity, Genome and Genetic association in the investigation of issues within Major depressive disorder.
His Psychiatry research is multidisciplinary, incorporating elements of Genetic predisposition and Malnutrition. His work in Single-nucleotide polymorphism and Copy-number variation are all subfields of Genetics research. His work is dedicated to discovering how Bipolar disorder, Mood are connected with Mood disorders and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Nature (2014)
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
Jordan W. Smoller;Kenneth Kendler;Nicholas John Craddock;Phil Hyoun Lee.
The Lancet (2013)
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda.
Nature Genetics (2010)
Hundreds of variants clustered in genomic loci and biological pathways affect human height
Hana Lango Allen;Karol Estrada;Guillaume Lettre;Sonja I. Berndt.
Nature (2010)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
Genome-wide association study identifies five new schizophrenia loci
Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson.
Nature Genetics (2011)
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Cathryn M. Lewis;Douglas F. Levinson;Lesley H. Wise;Lynn E. DeLisi.
American Journal of Human Genetics (2003)
Common variants on chromosome 6p22.1 are associated with schizophrenia
Jianxin Shi;Douglas F. Levinson;Jubao Duan;Alan R. Sanders.
Nature (2009)
Identification of loci associated with schizophrenia by genome-wide association and follow-up
Michael C. O'Donovan;Nicholas Craddock;Nadine Norton;Hywel Williams.
Nature Genetics (2008)
A mega-analysis of genome-wide association studies for major depressive disorder
Stephan Ripke;Naomi R Wray;Cathryn M Lewis;Steven P Hamilton.
Molecular Psychiatry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
NorthShore University HealthSystem
NorthShore University HealthSystem
University of Queensland
National Institutes of Health
Massachusetts General Hospital
NorthShore University HealthSystem
Columbia University
University of North Carolina at Chapel Hill
University of Tartu
Harvard University
University of Pittsburgh
Qualcomm (United States)
National Institute of Standards and Technology
Brigham Young University
University of Quebec at Montreal
Lancaster University
Xunta de Galicia
University of Kentucky
Institut Pasteur
University College London
ETH Zurich
Genentech
Gettysburg College
European Institute of Oncology
University of Maryland, Baltimore
University of Bologna